Navigation Links
HemaQuest Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
Date:4/25/2011

SAN DIEGO, April 25, 2011 /PRNewswire/ -- HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that clinical investigators have enrolled the first patient in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease. The study, which is being conducted by investigators in clinical sites in the US, Canada, Jamaica, Egypt and Lebanon, is expected to enroll approximately 50 patients. The primary objective is safety and tolerability of HQK-1001. There are several secondary objectives including an increase in fetal hemoglobin production. HemaQuest expects interim results from the study in late 2011 and final results in the first quarter of 2012.

"Based on the promising results from our prior Phase 2 clinical studies, we are excited to initiate this clinical study testing higher dose levels and longer duration of therapy to more fully characterize the therapeutic potential of HQK-1001 in sickle cell disease," said HemaQuest Chief Medical Officer Richard G. Ghalie, MD. "This is an important next step toward potentially making HQK-1001 available as a treatment for this devastating disease in underserved populations around the world."

ABOUT HQK-1001 HQK-1001 belongs to a class of compounds originally discovered at Boston University School of Medicine. These compounds, designated as Short Chain Fatty Acid Derivatives (SCFADs), have been shown to stimulate fetal hemoglobin expression and red blood cell production in the laboratory and in small clinical trials in patients with hemoglobin disorders, including sickle cell disease and beta thalassemia.  Increased fetal hemoglobin production in red blood cells has been shown to reduce the frequency of pain crises and hospitalizations  of patients with sickle cell disease  HQK-1001 is an orally administered SCFAD, which has shown an excellent safety profile a
'/>"/>

SOURCE HemaQuest Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
2. HemaQuest Announces Appointment of New Executive Management Team; Company Establishes Headquarters in San Diego
3. HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014 According to the ... Pre-packed, Analytical, Preparative), by Material (Metal, Glass, Plastic), by ... Forecast to 2018", published by MarketsandMarkets, the Chiral Chromatography ... is poised to grow at a CAGR of 5.2% ... Browse 90 market data tables and 15 ...
(Date:9/2/2014)... , Registry provides new insights ... and treatment satisfaction [ 1 ] ...        (Photo: http://photos.prnewswire.com/prnh/20140902/703596 ... Barcelona, Spain : Daiichi Sankyo today ... events-European Registry in Atrial Fibrillation (PREFER in AF), revealing ...
(Date:9/2/2014)... the Netherlands , Sept. 2, 2014 /PRNewswire/ ... North American operations through its subsidiary HealthLink International, by ... order to cash services for medical device manufacturers, throughout ... ERP platform. Building on the experience we ... Europe with customer service, VAT deferment, ...
Breaking Medicine Technology:Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 2One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 3One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 5One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 6One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 7One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 8HealthLink Europe opens North American medical warehouse operation 2
(Date:9/2/2014)... (PRWEB) September 03, 2014 UWDress.com, an ... gowns, has added a lot of fashionable bridesmaid ... more, the company has launched a special offer to ... discounted price, from 20 to 60 percent off. ... happy to announce our new fashionable bridesmaid dresses for ...
(Date:9/2/2014)... iFitDress.com, a famous online supplier of wedding dresses and ... 2014 seashell wedding dresses . Additionally, these elegant ... proportion of them are priced under $190. , All ... by the most skilled workers. Along with seashell wedding ... wedding gowns, white halter wedding gowns, regency evening outfits, ...
(Date:9/2/2014)... Washington, DC (PRWEB) September 02, 2014 TCG, ... named by Inc. 5000 as one of the fastest-growing companies ... the eighth time total. TCG was previously recognized in 2013, ... 2001. , TCG’s revenue has grown 86% from 2010 to ... of the fastest growing businesses in America - up 635 ...
(Date:9/2/2014)... On August 30, 2014, Harper’s Bazaar Magazine ... Should Wash Your Face .” According to the ... breathes air considered polluted by the World Health Organization. ... skin’s pores destroying its natural oils. These oils act ... may cause cell damage, redness, aging skin , ...
(Date:9/2/2014)... their own spread throughout the body by coaxing cells ... to a new report by Johns Hopkins scientists. , ... Communications , the researchers describe animal and cell-culture experiments ... by breast cancer cells. These molecules cause lymphatic endothelial ... produce proteins called CCL5 and VEGF. CCL5 attracts tumor ...
Breaking Medicine News(10 mins):Health News:Elegant Bridesmaid Dresses For 2014, Latest Designs From UWDress.com 2Health News:Discounted Seashell Wedding Dresses Currently Provided By iFitDress.com 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2
... Mount Sinai and ... , ... 29, 2010 -- In a statewide study, The Mount Sinai Hospital in Manhattan – along ... Department of Health as the hospital with the most successful record in performing angioplasty, a ...
... ... will join thousands of gastroenterologists from around the world to launch the first international ... Disease Week (DDW) annual conference (May 2 -5) in New Orleans. , ... New York, New York (Vocus) ...
... motivated people to get vaccinated, experts say ... by concerns about the recently discovered H1N1 swine flu ... and younger adults -- got seasonal flu shots during ... , The increases in seasonal flu vaccinations -- which ...
... ... Victory: Cortical Concepts Wins ,Wharton Business Plan Competition Michelson Grand Prize with ,Device ... with Private Sales for Co-eds, , ... Philadelphia, PA (PRWEB) April 29, 2010 -- The ...
... ... Office of Science and Technology Policy, will bring together leaders in open innovation ... Washington, DC (Vocus) ... and Open Grant Making”, a public-private strategy session jointly hosted by the White House ...
... of researchers at the University of Georgia and Emory University ... the National Institutes of Health to study the neurobiological mechanisms ... "Drug abuse is closely linked to stress, and ... preventing the relapse caused by stress," said Philip Holmes, professor ...
Cached Medicine News:Health News:The Mount Sinai Hospital Earns Highest Ratings in New York State Report on Coronary Angioplasty 2Health News:The Mount Sinai Hospital Earns Highest Ratings in New York State Report on Coronary Angioplasty 3Health News:The Mount Sinai Hospital Earns Highest Ratings in New York State Report on Coronary Angioplasty 4Health News:The Mount Sinai Hospital Earns Highest Ratings in New York State Report on Coronary Angioplasty 5Health News:The Mount Sinai Hospital Earns Highest Ratings in New York State Report on Coronary Angioplasty 6Health News:First Annual Observance of World IBD Day Draws Awareness to Growing Global Incidence of Inflammatory Bowel Disease 2Health News:First Annual Observance of World IBD Day Draws Awareness to Growing Global Incidence of Inflammatory Bowel Disease 3Health News:First Annual Observance of World IBD Day Draws Awareness to Growing Global Incidence of Inflammatory Bowel Disease 4Health News:First Annual Observance of World IBD Day Draws Awareness to Growing Global Incidence of Inflammatory Bowel Disease 5Health News:Record Number of Americans Got Flu Shots, CDC Says 2Health News:Record Number of Americans Got Flu Shots, CDC Says 3Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 2Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 3Health News:Prize4Life Featured in Major Innovation/Prize National Conference 2Health News:Prize4Life Featured in Major Innovation/Prize National Conference 3Health News:UGA, Emory to study how exercise may prevent drug abuse relapse 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: